Aimei Health Technology Co., Ltd ( (AFJK) ) has released a notification of late filing.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Aimei Health Technology Co., Ltd has filed a Form 12b-25 to notify investors of a delay in submitting its Form 10-K (Yearly Report) for the fiscal year ended December 31, 2025. The company’s principal office is in New York, and the late filing relates specifically to its annual report.
The company states that it could not complete the review process for the Form 10-K (Yearly Report) in time for the original SEC deadline. No issues such as auditor changes, restatements, or internal control failures are cited, suggesting the delay stems mainly from timing and review workload.
Aimei indicates it expects to file the delayed Form 10-K (Yearly Report) within the standard 15-calendar-day extension window allowed under SEC rules. This signals management’s intention to resolve the delay quickly rather than a prolonged reporting problem.
The company does not anticipate any significant change in its operating results compared with the prior fiscal year, based on the earnings information that will appear in the forthcoming Form 10-K (Yearly Report). As with all such notifications, these expectations are inherently forward-looking and remain subject to final audit and review outcomes.
Aimei confirms that all other required periodic reports over the last 12 months have been filed on time, underlining an otherwise clean compliance history. The notification is signed on April 1, 2026, by Chief Executive Officer and Director Junheng Xie, affirming the company’s ongoing commitment to meet SEC reporting obligations.
More about Aimei Health Technology Co., Ltd
Average Trading Volume: 17,973
Technical Sentiment Signal: Buy
Current Market Cap: $150M
Learn more about AFJK stock on TipRanks’ Stock Analysis page.